Search for Trading Method using Google

Custom Search
Showing posts with label Growth. Show all posts
Showing posts with label Growth. Show all posts

Sunday, October 10, 2010

China's CNOOC Poised for Growth

Not to beat a dead horse, but we’re still impressed with China’s control over its fast growing economy. While the Chinese GDP down-throttled to single digits in the second quarter of the year, recent data points to a reacceleration. Among recently released figures, Chinese imports in August were exceptionally impressive. Imports grew by 35.2 percent during the month over the year earlier period, a vast improvement over July’s 22.7 percent growth, and easily outpacing expectations of 27.5 percent. The remarkable import number goes part in parcel with strong retail sales and industrial production reports as well. China’s economic strength is also evident in commodity and energy prices. Even with the largest economies in the world, the U.S. and Europe, struggling to make strides in their recoveries, the most economically sensitive resources are pointing higher. Case in point is copper which is holding steady just below $3.50 a pound. Another is crude oil, while pulling back a tad over the last couple days, remains above $75 a barrel. As the developed economies recover (be it with or without more government intervention), and the developing world continues to pursue energy intensive infrastructure projects, worldwide oil demand will continue to move higher. Most easy to reach oil supplies have been or are close to, exhausted, and the world’s turning more towards deepwater deposits to satisfy its oil thirst. It’s not surprising to see the better capitalized oil companies going after the rights to such deposits – many of which are located off the coast of Brazil.

View the Original article

Saturday, October 9, 2010

Why Asian Currency Interventions Will Create Sub-Optimal Economic Growth

Yesterday in The Economist, there was an interesting article arguing in favor of currency interventions: Monetary Policy: Beggar, then Sneakily Enrich, Thy Neighbor.

The basic thrust of the author’s position is that Asian currency interventions will create inflationary pressures, which would allow world economies to slowly escape recession. Currency interventions are also favorably compared to eliminating the gold standard during the Great Depression.

Unfortunately, the author might be missing the underlying reason why the elimination of the gold standard allowed for economic recovery in the Depression. Instead, the currency interventions might be better compared to the disastrous Smoot-Hawley Tariff Act in the United States.

It wasn’t merely that the elimination of the gold standard created inflation. The underlying issue was that the gold standard created arbitrary and inflexible monetary policy during the Depression. By doing this, it prevented market forces from operating and money supply was artificially suppressed. As money supply was distorted, the market was deterred from reaching an optimal growth result.

There were only two ways to fix the imbalance: (a) discover a large amount of new gold deposits and mine them or (b) eliminate the gold standard. As gold is a scarce good and world population was rapidly rising in the late 19th and early 20th Centuries, (a) was becoming an increasingly difficult proposition. For this reason, elimination of the gold standard was the only real solution. And it worked magnificently, as every economy that eliminated the gold standard was able to greatly ease the Depression. In fact, China, which was on the silver standard, was almost able to miss the Depression entirely.

The current situation has a lot of parallels, unfortunately. Mercantilistic currency interventions artificially constrain money supply, just like the gold standard did during the Depression. More importantly, the interventions fuel large trade imbalances.

It's not simply a matter of "creating inflation" in one nation --- the issue runs much deeper than that. By not allowing market forces to operate, some nations run massive current account surpluses (e.g. Japan, China) while others run massive current account deficits (e.g. US, UK, Spain).

Essentially, we're cheating the free market. It doesn't matter if an American or Spanish firm can more efficiently manufacture widgets than a Japanese or Chinese firm --- by intervening in the currency markets, it is arbitrarily dictated that the Japanese or Chinese firm wins out. However, the issue with this is that it produces inefficiencies. It might even be creating negative growth because more efficient firms are being pushed out of the market in favor of more inefficient firms.

On the other side of the equation, the currency interventions are actively harming Asian consumers. While these interventions can help create GDP growth, they do so at the expense of Asian wage-workers. Wealth is redistributed primarily to two groups: (a) American consumers and (b) the owners of capital of Chinese and/or Japanese exporters.

Or in other words, these currency interventions create over-consumption in the US and under-consumption in East Asia. Equilibrium is not allowed to occur and sub-optimal growth (or even economic contraction) results as economic efficiencies are destroyed.

Just to make things worse, the constant tug of war between market forces and the interventions creates greater economic instability that produces huge bubbles and busts. While Alan Greenspan and Congress should be given some credit for helping to create the housing bubble in the US, Chinese currency policy also deserves its share of the blame, as the constant currency interventions artificially lowered interest rates in America, helping provide more fuel to the housing boom.

It's worth noting that in spite of Chinese and Japanese currency interventions, both nations have eventually run into a brick wall where they have deprived their consumers of so much of their 'earnings', that they simply cannot afford it any more. This is happening in China right now, as Chinese workers are forced to demand greater compensation in order to deal with rising costs-of-living It also appeared to occur in Japan in the mid-80’s before the Plaza Accord, as Japanese economic growth had been waning after a nearly three-decade long boom.

For these reasons, the currency interventions might be more like the Smoot-Hawley Tariff than the elimination of the gold standard. Smoot-Hawley attempted to fix global trade imbalances by promoting trade barriers that created more imbalances. Inevitably, European nations retaliated against the United States and the tariff only exacerbated the crisis.

While currency interventions have a different economic effect, the end result is the same: economic efficiencies are deterred and sub-optimal growth becomes more likely. Until the international currency system is reformed and these mercantilistic trade wars in Asia are eliminated, we may continue to see a poor worldwide economic environment.

Disclosure: No positions in any currencies or national ETFs.

About the author: H.J. Huneycutt

View the Original article

Tuesday, October 5, 2010

China: Recovery Consolidating but Slower Growth Ahead

Rising labor costs, a slowing recovery in the advanced economies, and expected reductions in China’s dependence on external demand will probably slow China’s growth to 7–8 percent in the years ahead. A significant slowdown, as feared for the United States, is unlikely, however. If domestic economic rebalancing—now recognized by top leaders in Beijing as absolutely necessary—accompanies this slowdown, it will be a good thing for China and for the rest of the world.

Overheating Largely Contained

China’s efforts to reduce overheating and control a potentially dangerous housing bubble have been largely successful so far. Although consumer price index (CPI) inflation, driven by food prices, grew in August, producer price inflation fell. In light of a probable decline in food prices later this year, the government’s 3 percent CPI inflation target for 2010 looks achievable.



View the Original article

Thursday, September 30, 2010

New Energy Systems: Hidden Gem With Strong Foundations for Growth

As a value investor, I am always looking for companies with great fundamentals and growth potential. By running my daily screen, a long candidate has attracted my eyes.

It is New Energy Systems Group (Amex: NEWN). NEWN is a leading provider of lithium-ion batteries for portable electronic devices in China with headquarters in Shenzhen, Guangdong Province, which is China's first—and arguably one of the most successful—Special Economic Zones. This company has recently been uplisted to Amex from OTCBB and trades in the range of $6-7.

In recent years, the global output of lithium-ion batteries has soared more than 50% annually and the demand is expected to maintain its upward momentum till 2018. At present, the global supply of Li-ion batteries is monopolized by three giants in Asia, i.e. China, Japan and South Korea, and all three have a total market share surpassing 95%.

The first use of lithium batteries was in laptops, but now they are widely used in cell phones, video machines, digital cameras, MP3 players, hybrid cars and other electronic products. The batteries are becoming more environment-friendly with a longer life, smaller size and lighter weight. Chinese Li-ion battery manufacturers are not only seizing market share for Li-ion batteries for portable products like 3G mobiles and laptops from South Korea and Japanese competitors, but also are actively developing the Li-ion battery market for electric cars and E-bicycles.

In China, the fastest-growing auto market in the world, the development of Li-ion batteries has become a core part of the development of hybrid cars. The Chinese government has recently handed out policy incentives to encourage more electric cars on the road and the demand for Li-ion batteries will increase. Investments into companies in the battery business will reward investors generously. In fact, this is already reflected in the Shanghai A-share market. Most Chinese battery companies listed in the A-share market have advanced more than 20% since August 1, 2010, with an incredible 100% net income increase in the first six months of 2010.

Products from NEWN now support iPhones, iPads (AAPL), Blackberrys (RIMM) and all major-brand cell phones, laptops, digital cameras, MP3s, etc. Currently, NEWN only operates at around 50% of manufacturing capacity and has begun to expand internationally. On August 26th, 2010, NEWN announced its plan to launch MeePower™, a new brand of advanced battery backup systems expected to be available to distributors in the U.S. beginning in the fall of 2010. MeePower generates 4–7 times more power than an original OEM battery’s capacity and can recharge the OEM battery more quickly and last longer.

In the past, the company only dealt in the low-margin battery shell & cap and battery-distribution businesses. But acquisitions in 2009 transformed NEWN into a rapidly-growing, high-margin, integrated manufacturer with an established brand name.

The first acquisition was of Anytone, a manufacturer and seller of lithium-ion battery finished products and was acquired by NEWN with both stock shares and cash payments. The acquisition not only enhances NEWN’s ability to rapidly innovate with quick-turn capabilities, over 30 patents and deep R&D capabilities, but also broadens product offering and allows NEWN to touch end-user customers.

Another acquisition was with NewPower, a China-based manufacturer of lithium-ion batteries. NewPower has extensive manufacturing expertise and capabilities. It only operates at 50% of production capacity and can triple its production with minimal additional capital expenditures. Both acquisitions are strategically important to vertical integration and increase profitability of the existing battery distribution business with added margins by internally sourcing lithium-ion batteries.

Although the company’s cash positions are influenced by its payments for the acquisitions, NEWN still shows strong second-quarter earnings. The company’s revenue has increased 335.2% to

View the Original article

Thursday, August 26, 2010

China: Where Micro Cap Growth Opportunities Abound

The demographics of China (population 1.34 billion) and India (population 1.19 billion) make them areas equity investors can not ignore. These two countries account for approximately 36.8% of total world population, while the United States ranks as a distant third with a population of 310 million or 4.5% of total world population.

In the future, the U.S. will benefit tangentially from the tremendous economic growth anticipated for China and India. Hopefully this will partially offset the negative economic headwinds fostered by the confluence of “Big Government,” “Big Business” and “Big Labor” (or should I say "Big & Corrupt"). I feel certain that most of us are not happy with the direction of the country, which began years before the current administration in Washington D.C. The recent actions are merely bringing a future crisis to a head at a quicker pace. It is unconscionable that the U.S. keeps falling deeper into debt and at an accelerating pace. We are becoming more and more beholding to China and other foreign nations to bail out our fiscal irresponsibility, which can only end up badly in the future.

I generally advise most individuals to invest in mutual funds to get the proper diversification of investments for areas like China, India and other emerging markets. However, I have come across a number of micro-caps in China that I find appealing for those with a speculative appetite. Recently we purchased shares of a small and rapidly growing Drug Store chain trading under the symbol CJJD.

China Jo-Jo Drugstores, Inc. (CJJD), through contractually controlled affiliates, operates a retail pharmacy chain in China offering both western and traditional Chinese medicine. The chain currently has 42 stores in Zhejiang Province. The Company had a public offering on 04-28-10, when they sold 3.5 million shares at $5.00 per share and the net proceeds to CJJD amounted to $15.45 million.

The company has a fiscal year that ends on March 31. Prior to raising the new capital in April 2010, they grew the number of directly operated drugstores from 9 at March 31, 2008, to 16 at March 31, 2009 and 25 at March 31, 2010. Since April 1, 2010 to date, they added another 17 stores bringing the current total up to 42 stores in Zhejiang Province. The company’s immediate goal is to have 60 drug stores in Zhejiang Province, which is an area of 39,300 square miles and having a population of 52 million. The Company’s longer term goal is to operate more than 200 drug stores by sometime between the fiscal years ending March 31, 2014 and March 31, 2015.

Other interesting demographics about Zhejiang Province include (source: Wikipedia List of China administrative divisions by GDP):

“Zhejiang is an eastern coastal and best developed province, its annual average GDP growth rate of 12.7% ranked the 2nd from 1978 to 2007, while its GDP per capita in 2007 was 112.2 times in 1978, it ranked 1st in all provincial-level divisions. In 1978, Zhejiang's GDP was only CNY12,372 million (US$7,347 million) and ranked the 12th in all 50 provincial-level divisions, then Its GDP has been Ranking the 4th since 1994, also Zhejiang became the 4th province to reach a GDP of over CNY1 trillion in 2004. In 2008, Zhejiang's GDP rose up to CNY 2,148,692 (US$309,677 million) and it was the first time to reach over CNY2 trillion. Zhejiang's GDP was CNY 2,283,243 million (US$334,247 million) in 2009.”

As of June 25, 2010 the company operated 31 stores. Each of their stores typically carries approximately 2,500 to 7,500 different products. In addition to these products, they have licensed doctors of both western medicine and TCM onsite for consultation, examination and treatment of common ailments at scheduled hours. Two of their stores have adjacent medical clinics offering urgent care (to provide treatment for minor ailments such as sprains, minor lacerations and dizziness which can be treated on an outpatient basis), TCM (including acupuncture, therapeutic massage and cupping) and minor outpatient surgical treatments (such as suturing). Included in their Q-1 2010 press release was the following announcement:

“Another milestone for us was that we are the first non-state-owned enterprise in Zhejiang Province to be able to sell pharmaceutical products online. The online drugstore will not be an immediate revenue generator for us, but over the long term we will use this to further establish our presence throughout Zhejiang Province.”

In the company’s conference call they played down the current impact of getting licensed to sell pharmaceuticals online but indicated this could have a big impact in the more distant future.

Their store locations vary in size, and the 31 stores operated as on June 25, 2010 averaged approximately 3,592 square feet. I believe the larger store size is one of the distinguishing factors, which accounts for the better operating results of CJJD versus other drug store chains operating in China, such as China Nepstar Chain Drugstore Ltd. (NPD), whose ADS shares are traded on the NYSE.

Sales of CJJD grew from $31.3 million in the FYE 03-31-08 to $44.8 million (up

View the Original article

How the Western Equity Markets Will Benefit From Chinese Growth

After the slowdown we had in the western economy, China has become the key economic engine for the global growth. Most of the time US equity markets look out for the Chinese market for its direction hoping that a continued growth in China will help the US companies. In my view Chinese economy has little to do with how the US companies will do in the short term. In my view structural changes taking place in China will help the US and European companies in the long run as these companies are better prepared to benefit from these changes.

Short term: It is US economic recovery that will drive the market, not the emerging market recovery

By looking at the most recent full year numbers available for S&P500 companies, it is clear that more than half of the revenue for US companies is generated within the US itself. Interestingly the numbers suggest that the significance of the US market increased over the last 3 years. So for the earnings growth of the US companies what matters are the developments taking place in the home market, not in the emerging markets.

Table 1: Geographical breakdown of revenue

2007

2008

2009

US

55%

56%

59%

EU

10%

12%

10%

UK

2%

1%

1%

Other

33%

31%

31%

100%

100%

100%

Source: Bloomberg

(Click charts to enlarge)

Chart 1: The significance of US market for the US companies


View the Original article

Tuesday, August 3, 2010

Baidu: Expecting Strong Q2 Results, Slower Q3 Growth

Expecting strong Q2 results. Chinese search engine operator Baidu (BIDU) will report 2Q10 results on July 21 after market close. For the quarter, I estimate Baidu generated $280 million revenue (up 48% Q/Q) and $0.33 GAAP EPS, significantly above management guidance of $268.1-274.0 million and consensus of $271.4 million. I attribute the strong growth in Q2 to three factors: advertisers ramping up spending after Chinese New Year, Baidu gaining market share after Google (GOOG) exited China mainland in late March, Phoenix Nest system achieving higher penetration among Baidu's advertising clients.

View the Original article